NASDAQ Biotechnology Index (NBI) Market Capitalization
Explore all companies in the NASDAQ Biotechnology Index ranked by market capitalization
Total Market Cap: $1.54 Trillion Constituents: 263 Country: USA
Total Market Cap (USD)
$1.54 Trillion
Constituent Companies
263
Index Country
USA
| Rank | Company | Weight (%) | Market Cap (USD) | Sector | Industry | Price | 24h Change |
|---|---|---|---|---|---|---|---|
| 201 |
LENZ Therapeutics Inc
NASDAQ:LENZ |
% | $250.65 Million | Healthcare | Biotechnology | $12.50 | +6.47% |
| 202 |
Aura Biosciences Inc
NASDAQ:AURA |
% | $249.36 Million | Healthcare | Biotechnology | $6.81 | +1.04% |
| 203 |
Lyell Immunopharma Inc
NASDAQ:LYEL |
% | $243.38 Million | Healthcare | Biotechnology | $20.14 | -4.69% |
| 204 |
Evolus Inc
NASDAQ:EOLS |
% | $227.80 Million | Healthcare | Drug Manufacturers - Specialty & Generic | $4.91 | -2.58% |
| 205 |
Larimar Therapeutics Inc
NASDAQ:LRMR |
% | $224.89 Million | Healthcare | Biotechnology | $4.38 | -0.45% |
| 206 |
Kyverna Therapeutics, Inc. Common Stock
NASDAQ:KYTX |
% | $223.25 Million | Healthcare | Biotechnology | $8.80 | -3.19% |
| 207 |
Entrada Therapeutics Inc
NASDAQ:TRDA |
% | $220.00 Million | Healthcare | Biotechnology | $12.59 | -1.18% |
| 208 |
2Seventy Bio Inc
NASDAQ:TSVT |
% | $213.50 Million | Healthcare | Biotechnology | $5.00 | +0.00% |
| 209 |
Atrium Therapeutics, Inc. Common Stock
NASDAQ:RNA |
% | $207.28 Million | Healthcare | Biotechnology | $13.77 | -0.15% |
| 210 |
PepGen Ltd
NASDAQ:PEPG |
% | $204.50 Million | Healthcare | Biotechnology | $5.09 | -4.86% |
| 211 |
SIGA Technologies Inc
NASDAQ:SIGA |
% | $203.61 Million | Healthcare | Drug Manufacturers - Specialty & Generic | $5.02 | -8.06% |
| 212 |
Voyager Therapeutics Inc
NASDAQ:VYGR |
% | $198.72 Million | Healthcare | Biotechnology | $3.92 | -9.26% |
| 213 |
Alector Inc
NASDAQ:ALEC |
% | $192.67 Million | Healthcare | Biotechnology | $2.23 | +0.90% |
| 214 |
Scpharmaceuticals Inc
NASDAQ:SCPH |
% | $185.50 Million | Healthcare | Biotechnology | $5.67 | +0.00% |
| 215 |
C4 Therapeutics Inc
NASDAQ:CCCC |
% | $184.28 Million | Healthcare | Biotechnology | $2.76 | +1.10% |
| 216 |
Humacyte Inc
NASDAQ:HUMA |
% | $182.16 Million | Healthcare | Biotechnology | $1.16 | +3.57% |
| 217 |
Editas Medicine Inc
NASDAQ:EDIT |
% | $177.67 Million | Healthcare | Biotechnology | $2.46 | -3.15% |
| 218 |
OmniAb Inc.
NASDAQ:OABI |
% | $177.13 Million | Healthcare | Biotechnology | $1.83 | +0.00% |
| 219 |
Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT |
% | $167.95 Million | Healthcare | Biotechnology | $6.39 | -3.62% |
| 220 |
Y mAbs Therapeutics
NASDAQ:YMAB |
% | $162.66 Million | Healthcare | Biotechnology | $8.61 | +0.23% |
| 221 |
ACELYRIN, INC. Common Stock
NASDAQ:SLRN |
% | $155.38 Million | Healthcare | Biotechnology | $2.27 | +0.00% |
| 222 |
Foghorn Therapeutics Inc
NASDAQ:FHTX |
% | $144.38 Million | Healthcare | Biotechnology | $5.06 | +1.81% |
| 223 |
CARGO Therapeutics, Inc. Common Stock
NASDAQ:CRGX |
% | $134.28 Million | Healthcare | Biotechnology | $4.47 | +0.00% |
| 224 |
AC Immune Ltd
NASDAQ:ACIU |
% | $133.04 Million | Healthcare | Biotechnology | $3.32 | +6.07% |
| 225 |
Nkarta Inc
NASDAQ:NKTX |
% | $130.63 Million | Healthcare | Biotechnology | $2.32 | +1.75% |
| 226 |
Autolus Therapeutics Ltd
NASDAQ:AUTL |
% | $127.35 Million | Healthcare | Biotechnology | $1.51 | +0.00% |
| 227 |
Inozyme Pharma Inc
NASDAQ:INZY |
% | $119.94 Million | Healthcare | Biotechnology | $4.00 | +0.00% |
| 228 |
Fate Therapeutics Inc
NASDAQ:FATE |
% | $113.90 Million | Healthcare | Biotechnology | $1.13 | -2.59% |
| 229 |
MacroGenics Inc
NASDAQ:MGNX |
% | $113.87 Million | Healthcare | Biotechnology | $3.08 | -0.65% |
| 230 |
Codexis Inc
NASDAQ:CDXS |
% | $112.91 Million | Healthcare | Biotechnology | $1.47 | -2.00% |
| 231 |
Neurogene Inc
NASDAQ:NGNE |
% | $109.83 Million | Healthcare | Biotechnology | $21.08 | -2.27% |
| 232 |
Mersana Therapeutics Inc
NASDAQ:MRSN |
% | $102.67 Million | Healthcare | Biotechnology | $29.08 | +0.14% |
| 233 |
Third Harmonic Bio Inc.
NASDAQ:THRD |
% | $83.95 Million | Healthcare | Biotechnology | $5.38 | +0.00% |
| 234 |
Eliem Therapeutics Inc
NASDAQ:ELYM |
% | $81.07 Million | Healthcare | Biotechnology | $3.09 | +0.00% |
| 235 |
Biomea Fusion Inc
NASDAQ:BMEA |
% | $80.34 Million | Healthcare | Biotechnology | $1.22 | -2.40% |
| 236 |
Sutro Biopharma
NASDAQ:STRO |
% | $79.09 Million | Healthcare | Biotechnology | $22.94 | -2.36% |
| 237 |
MaxCyte Inc
NASDAQ:MXCT |
% | $77.55 Million | Healthcare | Medical Devices | $0.80 | -1.36% |
| 238 |
IGM Biosciences Inc
NASDAQ:IGMS |
% | $76.57 Million | Healthcare | Biotechnology | $1.27 | -2.31% |
| 239 |
Pliant Therapeutics Inc
NASDAQ:PLRX |
% | $67.62 Million | Healthcare | Biotechnology | $1.33 | +1.53% |
| 240 |
Pyxis Oncology Inc
NASDAQ:PYXS |
% | $66.88 Million | Healthcare | Biotechnology | $1.62 | -2.99% |
| 241 |
Cartesian Therapeutics Inc.
NASDAQ:RNAC |
% | $66.68 Million | Healthcare | Biotechnology | $7.18 | -2.05% |
| 242 |
Tscan Therapeutics Inc
NASDAQ:TCRX |
% | $51.36 Million | Healthcare | Biotechnology | $1.09 | +2.83% |
| 243 |
Artiva Biotherapeutics, Inc. Common Stock
NASDAQ:ARTV |
% | $34.17 Million | Healthcare | Biotechnology | $6.32 | +2.27% |
| 244 |
Q32 Bio Inc
NASDAQ:QTTB |
% | $33.88 Million | Healthcare | Biotechnology | $6.13 | -2.70% |
| 245 |
Alpha Teknova Inc
NASDAQ:TKNO |
% | $29.86 Million | Healthcare | Drug Manufacturers - Specialty & Generic | $2.88 | -4.32% |
| 246 |
Acrivon Therapeutics, Inc. Common Stock
NASDAQ:ACRV |
% | $27.87 Million | Healthcare | Biotechnology | $1.66 | -2.35% |
| 247 |
Applied Therapeutics Inc
NASDAQ:APLT |
% | $12.34 Million | Healthcare | Biotechnology | $0.10 | +0.00% |
| 248 |
Bicycle Therapeutics Ltd
NASDAQ:BCYC |
% | $9.55 Million | Healthcare | Biotechnology | $5.07 | +0.40% |
| 249 |
Tevogen Bio Holdings Inc
NASDAQ:TVGN |
% | $2.96 Million | Healthcare | Biotechnology | $5.17 | -7.35% |
| 250 |
PTC Therapeutics Inc
NASDAQ:PTCT
|
% | - | Healthcare | Biotechnology | - | - |
Complete list of all companies in the NBI index ranked by market capitalization. Track index constituent performance and market values. View all indices